Oral Glucose-Lowering Agent Treatments in Type 2 Diabetes Mellitus
Type 2 diabetes is manifested by impaired insulin secretion in pancreatic beta cells, increased glucagon secretion in alpha cells, and generally has a history of insulin resistance. The treatment of glucose metabolism disorder and the resulting hyperglycemia constitute an important part of the treat...
| 1. autor: | |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
Nizameddin KOCA
2021-01-01
|
| Seria: | Turkish Journal of Internal Medicine |
| Hasła przedmiotowe: | |
| Dostęp online: | https://dergipark.org.tr/tr/download/article-file/1361763 |